ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Online 2668-8212
ISSN Print: 1582-9049
ISSN-L: 1582-9049

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 76, 2025
   Volume 75, 2024
   Volume 74, 2023
   Volume 73, 2022
   Volume 72, 2021
   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2016, Volume 67, Issue 9,





Lacramioara PAVAL, Daniel PAVAL, Cristian Dinu POPESCU
Procognitive Effects of Immunomodulatory, Anticholinergic and Glutamatergic Medication in Multiple Sclerosis

Abstract:

Multiple sclerosis is the most common neurological disorder present in young population, with neurological and psychiatric disabilities. Cognitive dysfunction can occur with the onset of multiple sclerosis. Therefore, these disorders are difficult to detect early, especially when neurological disability therapy outweigh the mental state. Various pharmacological agents have been studied in order to control the cognitive impairment in multiple sclerosis. Chemical substances with immunomodulatory effect such as interferon-beta and glatiramer acetate are the first indicated in therapy. Their purpose is to reduce organic brain damage by modulating the immune response. Specific pharmacological agents with procognitive action, used in dementia treatment, correct the neuro-bio-chemical deficit that is the consequence of neuronal dysfunction and degradation that appears in multiple sclerosis evolution. Procognitive effect of these medicines stems from the anticholinergic and glutamatergic action which increases levels of acetylcholine in the brain and moderates glutamate activity reducing oxidative stress. This paper presents an analysis of studies that highlight the procognitive effects of immunomodulatory, anticholinergic and glutamatergic pharmacological agents in multiple sclerosis. Keywords: interferon-beta, glatiramer acetate, acetylcholine, procognitive effect, multiple sclerosis

Issue: 2016, Volume 67, Issue 9
Pages:
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie NUMAR OMAGIAL PETRU PONI.. detalii
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice